1,3-DI-O-TOLYLGUANIDINE
General Information
Mainterm | 1,3-DI-O-TOLYLGUANIDINE |
CAS Reg.No.(or other ID) | 97-39-2 |
Regnum |
177.2600 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 7333 |
IUPAC Name | 1,2-bis(2-methylphenyl)guanidine |
InChI | InChI=1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18) |
InChI Key | OPNUROKCUBTKLF-UHFFFAOYSA-N |
Canonical SMILES | CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N |
Molecular Formula | C15H17N3 |
Wikipedia | 1,3-di-O-tolylguanidine |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 239.322 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 3 |
Complexity | 288.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B z A A A A A A A A A A A A A A A A A A A A A A A A A A A w Y A A A A A A A A A A B Q A A A H A A Q A A A A D A i B G A A z w I L A A A C g A i R C Z A C C A A E h A g A J i A A A Z I i I I C L A m Z G E I A h g k A J I y C c Q g A A O A A A A A A A C A A A A A A A A A A Q A A A A A A A A A A A = = |
Topological Polar Surface Area | 50.4 |
Monoisotopic Mass | 239.142 |
Exact Mass | 239.142 |
XLogP3 | None |
XLogP3-AA | 3.1 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 18 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.7914 |
Human Intestinal Absorption | HIA+ | 0.9600 |
Caco-2 Permeability | Caco2+ | 0.5777 |
P-glycoprotein Substrate | Non-substrate | 0.6420 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8616 |
Non-inhibitor | 0.8160 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.6736 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5671 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7388 |
CYP450 2D6 Substrate | Non-substrate | 0.7377 |
CYP450 3A4 Substrate | Non-substrate | 0.7226 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9139 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9230 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9230 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9484 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9072 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5422 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9582 |
Non-inhibitor | 0.8740 | |
AMES Toxicity | AMES toxic | 0.7332 |
Carcinogens | Non-carcinogens | 0.6081 |
Fish Toxicity | High FHMT | 0.8329 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9966 |
Honey Bee Toxicity | Low HBT | 0.7993 |
Biodegradation | Not ready biodegradable | 0.9890 |
Acute Oral Toxicity | III | 0.7213 |
Carcinogenicity (Three-class) | Non-required | 0.5342 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.9179 | LogS |
Caco-2 Permeability | 1.0145 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.8641 | LD50, mol/kg |
Fish Toxicity | 1.5688 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.1039 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Benzenoids |
Class | Benzene and substituted derivatives |
Subclass | Toluenes |
Intermediate Tree Nodes | Not available |
Direct Parent | Toluenes |
Alternative Parents | |
Molecular Framework | Aromatic homomonocyclic compounds |
Substituents | Toluene - Guanidine - Organic nitrogen compound - Organopnictogen compound - Hydrocarbon derivative - Organonitrogen compound - Imine - Aromatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as toluenes. These are compounds containing a benzene ring which bears a methane group. |
From ClassyFire